Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.5943
-0.0287 (-4.60%)
Feb 6, 2026, 4:00 PM EST - Market closed
Vaxart Market Cap
Vaxart has a market cap or net worth of $142.63 million as of February 6, 2026. Its market cap has decreased by -18.54% in one year.
Market Cap
142.63M
Enterprise Value
135.83M
1-Year Change
-18.54%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from $60.35M to $142.63M, an increase of 136.33%. That is a compound annual growth rate of 11.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 145.67M | 75.23% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nkarta | 157.69M |
| Acumen Pharmaceuticals | 155.67M |
| Cibus | 154.03M |
| Corbus Pharmaceuticals Holdings | 150.08M |
| Rani Therapeutics Holdings | 149.47M |
| Unicycive Therapeutics | 148.72M |
| Connect Biopharma Holdings | 148.14M |
| NovaBay Pharmaceuticals | 146.36M |